Annual Cash & Cash Equivalents
$5.29 M
-$426.30 K-7.46%
September 30, 2023
Summary
- As of February 8, 2025, UPC annual cash & cash equivalents is $5.29 million, with the most recent change of -$426.30 thousand (-7.46%) on September 30, 2023.
- During the last 3 years, UPC annual cash & cash equivalents has fallen by -$4.77 million (-47.45%).
- UPC annual cash & cash equivalents is now -47.45% below its all-time high of $10.06 million, reached on September 30, 2020.
Performance
UPC Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$8.86 M
+$3.58 M+67.67%
March 31, 2024
Summary
- As of February 8, 2025, UPC quarterly cash and cash equivalents is $8.86 million, with the most recent change of +$3.58 million (+67.67%) on March 31, 2024.
- Over the past year, UPC quarterly cash and cash equivalents has dropped by -$4.09 million (-31.59%).
- UPC quarterly cash and cash equivalents is now -75.38% below its all-time high of $36.00 million, reached on March 31, 2021.
Performance
UPC Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
UPC Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -7.5% | -31.6% |
| 3 y3 years | -47.5% | -75.4% |
| 5 y5 years | -14.6% | - |
UPC Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -34.6% | at low | -37.8% | +67.7% |
| 5 y | 5-year | -47.5% | +66.3% | -75.4% | +178.9% |
| alltime | all time | -47.5% | +66.3% | -75.4% | +178.9% |
Universe Pharmaceuticals Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2024 | - | $8.86 M(+67.7%) |
| Sep 2023 | $5.29 M(-7.5%) | $5.29 M(-59.2%) |
| Mar 2023 | - | $12.95 M(+126.8%) |
| Sep 2022 | $5.71 M(-29.3%) | $5.71 M(-59.9%) |
| Mar 2022 | - | $14.24 M(+76.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2021 | $8.08 M(-19.7%) | $8.08 M(-77.6%) |
| Mar 2021 | - | $36.00 M(+257.9%) |
| Sep 2020 | $10.06 M(+216.6%) | $10.06 M(-14.7%) |
| Mar 2020 | - | $11.80 M(+271.3%) |
| Sep 2019 | $3.18 M(-48.7%) | $3.18 M |
| Sep 2018 | $6.19 M | - |
FAQ
- What is Universe Pharmaceuticals annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Universe Pharmaceuticals?
- What is Universe Pharmaceuticals annual cash & cash equivalents year-on-year change?
- What is Universe Pharmaceuticals quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Universe Pharmaceuticals?
- What is Universe Pharmaceuticals quarterly cash and cash equivalents year-on-year change?
What is Universe Pharmaceuticals annual cash & cash equivalents?
The current annual cash & cash equivalents of UPC is $5.29 M
What is the all time high annual cash & cash equivalents for Universe Pharmaceuticals?
Universe Pharmaceuticals all-time high annual cash & cash equivalents is $10.06 M
What is Universe Pharmaceuticals annual cash & cash equivalents year-on-year change?
Over the past year, UPC annual cash & cash equivalents has changed by -$426.30 K (-7.46%)
What is Universe Pharmaceuticals quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of UPC is $8.86 M
What is the all time high quarterly cash and cash equivalents for Universe Pharmaceuticals?
Universe Pharmaceuticals all-time high quarterly cash and cash equivalents is $36.00 M
What is Universe Pharmaceuticals quarterly cash and cash equivalents year-on-year change?
Over the past year, UPC quarterly cash and cash equivalents has changed by -$4.09 M (-31.59%)